Hyllengren Eric J
Insider CIK 1966926 · ATRA SVP, CFO · ZURA Chief Financial Officer · TNYA Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TNYA Tenaya Therapeutics, Inc. | A Award deriv | 2026-07-13 | 2026-07-14 | 1,650,000 | — | $0 | 1,650,000 | SEC↗ |
| ZURA Zura Bio Ltd | A Award deriv | 2026-04-01 | 2026-04-02 | 340,900 | — | $0 | 340,900 | SEC↗ |
| ZURA Zura Bio Ltd | A Award deriv | 2025-07-15 | 2025-07-17 | 672,000 | — | $0 | 672,000 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 154 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 496 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 381 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 350 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 262 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 331 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 8,961 | — | $0 | 2,656 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 1,900 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 460 | — | $0 | 0 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | D To issuer deriv | 2025-03-31 | 2025-04-02 | 543 | — | $0 | 160 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2025-03-03 | 2025-03-05 | 1,211 | $7.00 | $8.5K | 56,231 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2025-01-27 | 2025-01-29 | 34,050 | — | $0 | 57,442 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2024-11-18 | 2024-11-20 | 1,364 | $11.20 | $15.3K | 23,392 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2024-08-16 | 2024-08-20 | 1,041 | $6.63 | $6.9K | 24,785 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2024-08-16 | 2024-08-20 | 29 | $6.63 | $192 | 24,756 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2024-05-16 | 2024-05-20 | 28,648 | $0.62 | $17.8K | 645,671 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2024-03-04 | 2024-03-06 | 5,217 | $0.72 | $3.8K | 674,319 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2024-03-04 | 2024-03-06 | 1,462 | $0.72 | $1.1K | 679,536 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | A Award | 2024-01-08 | 2024-01-09 | 475,000 | — | $0 | 680,998 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2023-11-16 | 2023-11-20 | 11,958 | $0.39 | $4.7K | 205,998 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2023-08-16 | 2023-08-18 | 1,778 | $1.65 | $2.9K | 217,956 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2023-08-16 | 2023-08-18 | 6,408 | $1.65 | $10.6K | 219,734 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2023-05-16 | 2023-05-18 | 6,199 | $2.04 | $12.6K | 227,861 | SEC↗ |
| ATRA Atara Biotherapeutics, Inc | S Sale | 2023-05-16 | 2023-05-18 | 1,719 | $2.04 | $3.5K | 226,142 | SEC↗ |